At a time of annual review and year-end conclusion, a number of major capital market events and award selections have been held intensively, and CMS has received two significant honors. On January 9, at the 2025 Hong Kong Wealth Management Summit and the 12th “Top 100 Hong Kong Listed Companies” Awards Ceremony, CMS was honored as the “Top 100 Hong Kong Listed Companies-Annual Pharmaceutical and Healthcare Innovation Pioneer”. Previously, on December 29, at the 2025 CLS 8th Investment Summit and the “Capital Market Most Value-Influential List” Awards Ceremony, CMS also received the “Most Investment Value Award”. Receiving two authoritative awards in short succession fully demonstrates the market’s high recognition of the Group’s comprehensive strength and long-term development value. As a highly credible selection event in the Hong Kong stock market, the “Top 100 Hong Kong Listed Companies” aims to identify companies listed on the Main Board with sound development […]
Learn More
Recently, the 2025 Deloitte China Technology Fast Program Award Ceremony was successfully held in Wuxi, China. After a three-month selection process, Dermavon, the skin health business company of CMS, was included in the list of “Deloitte China LSHC Rising Star” by virtue of its leading innovative product layout in the skin health field, as well as its promising growth and development potential. The theme of this year’s “Technology Fast Program” selection is “Boundless Innovation, Resilient Growth”. Through the review by the Professional Committee, enterprise presentation and scoring, and other processes, the selection comprehensively evaluates enterprise valuation, technological innovation, market prospects, industry ranking, etc., and selects excellent enterprises with both innovation capabilities and growth potential, so as to encourage enterprises to break through technological boundaries and promote the continuous construction of the innovation ecosystem. Being selected into this list is a full recognition of Dermavon’s leading industry position, comprehensive and differentiated innovative product portfolio, […]
Learn MoreThe news on this page is intended to share cutting-edge medical information and is for academic reference only by medical and health professionals, not for advertising purposes. CMS does not recommend any drugs, medical devices and/or indications. The news information on this page is for reference only. Please follow the advice or guidance of your doctor or other healthcare professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. If you have understood and confirmed the above content, please click OK to enter.
